UNICA IRIS Institutional Research Information System

CASTELLI, MARIA PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 133.464
NA - Nord America 8.268
AS - Asia 2.948
SA - Sud America 414
Continente sconosciuto - Info sul continente non disponibili 321
AF - Africa 79
OC - Oceania 13
Totale 145.507
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 129.855
US - Stati Uniti d'America 8.128
NL - Olanda 1.900
SG - Singapore 1.203
CN - Cina 991
SE - Svezia 410
UA - Ucraina 376
BR - Brasile 308
VN - Vietnam 236
DE - Germania 218
GB - Regno Unito 199
FI - Finlandia 168
FR - Francia 139
HK - Hong Kong 109
CA - Canada 93
IN - India 90
KR - Corea 57
BD - Bangladesh 49
AR - Argentina 39
PL - Polonia 39
JP - Giappone 36
RU - Federazione Russa 28
IQ - Iraq 23
AT - Austria 20
BE - Belgio 20
ZA - Sudafrica 20
ID - Indonesia 19
ES - Italia 18
MX - Messico 18
TR - Turchia 18
MA - Marocco 17
UZ - Uzbekistan 16
CZ - Repubblica Ceca 14
PH - Filippine 14
SA - Arabia Saudita 14
CL - Cile 13
EC - Ecuador 13
CO - Colombia 12
VE - Venezuela 12
AU - Australia 10
IE - Irlanda 10
TN - Tunisia 10
IL - Israele 9
KE - Kenya 9
PK - Pakistan 9
CH - Svizzera 8
MY - Malesia 8
PE - Perù 8
EG - Egitto 7
JM - Giamaica 7
EU - Europa 6
CR - Costa Rica 5
IR - Iran 5
JO - Giordania 5
NO - Norvegia 5
PY - Paraguay 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
PR - Porto Rico 4
PT - Portogallo 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
AZ - Azerbaigian 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
LV - Lettonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
DZ - Algeria 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
GF - Guiana Francese 1
GH - Ghana 1
IS - Islanda 1
KW - Kuwait 1
OM - Oman 1
Totale 145.188
Salva come PNG Salva come JPEG
Città #
Cagliari 126.819
Uta 2.670
Amsterdam 1.871
Ashburn 683
Fairfield 612
Singapore 607
Dallas 599
Woodbridge 481
San Jose 476
Chandler 416
Houston 416
Boardman 277
Ann Arbor 269
Seattle 239
Wilmington 236
Nyköping 231
Jacksonville 206
Cambridge 202
Beijing 187
Los Angeles 145
Council Bluffs 144
Dearborn 136
Santa Clara 114
New York 112
The Dalles 102
Helsinki 101
Hong Kong 96
Shanghai 86
Hefei 82
Ho Chi Minh City 74
Lauterbourg 71
Boston 69
Nanjing 63
Munich 62
Seoul 57
Hanoi 51
Buffalo 46
Orem 38
San Diego 38
Atlanta 34
Denver 34
Nanchang 31
San Francisco 31
Brooklyn 30
Chicago 29
Dong Ket 29
Frankfurt am Main 29
London 29
Columbus 28
Milan 28
Tokyo 28
Warsaw 28
Washington 26
Hebei 25
Montreal 25
Phoenix 23
Shenyang 23
Mountain View 22
Redwood City 22
Tianjin 22
Toronto 22
Rome 21
Guangzhou 20
Changsha 18
Chennai 18
Stockholm 18
Verona 18
Sassari 17
São Paulo 17
Brussels 16
Jiaxing 16
Jinan 15
Norwalk 15
Redondo Beach 15
Nuremberg 14
Tashkent 14
Johannesburg 13
Vienna 13
Falls Church 12
Haiphong 11
Hangzhou 11
Wuhan 11
Baghdad 10
Auburn Hills 9
Casablanca 9
Dhaka 9
Dublin 9
Paris 9
Pittsburgh 9
Orange 8
Philadelphia 8
Tampa 8
Victoria 8
Brasília 7
Brno 7
Buenos Aires 7
Manchester 7
Mumbai 7
New Delhi 7
Piscataway 7
Totale 140.250
Salva come PNG Salva come JPEG
Nome #
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.820
Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice 5.243
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.146
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.184
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 4.164
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.918
Regional distribution of 5α-reductase type 2 in the adult rat brain: An immunohistochemical analysis 3.559
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.239
The agression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake. 3.186
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.103
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.968
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penilemerection: immunohistochemistry,autoradiography and behavvioral studies 2.792
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.713
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 2.679
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.629
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.611
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.603
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.575
Suppressing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on chocolate self-administration and reinstatement of chocolate seeking in rats 2.521
In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator 2.477
The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, regulates hippocampal aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties. 2.410
Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotoninergic toxicity 2.395
Cannabis and the Use of Amphetamine-Like Substances 2.363
The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: Involvement of paraventricular glutamic acid and nitric oxide 2.357
In vitro functional characterization of GET73 as possible negative allosteric modulator of metabotropic glutamate receptor 5 2.268
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.155
Characterization of COR627 and COR628, Two Novel Positive Allosteric Modulators of the GABAB Receptor. 2.111
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB(1) cannabinoid receptors 2.086
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 2.085
null 2.010
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe 1.952
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.940
Distribution and localization of the GABAB receptor 1.940
Persistent increase in CB1 receptor and amnestic effect of cannabinoid by methamphetamine 1.908
null 1.888
(-) S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors 1.833
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.823
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioural studies 1.807
Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73. 1.712
Localization of steroid 5α-reductase type 2 isozyme in the adult rat brain 1.704
Differential G-protein coupling to GABAB receptor in limbic areas of alcohol-preferring and -nonpreferring rats 1.693
A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor 1.542
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.483
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 1.402
Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors 1.391
Sex and gender differences in the effects of novel psychoactive substances 1.377
Changes induced by acute toxic dose (ATD) of methanphetamine (METH) on cannabinoid CB1 receptors: An immunocytochemistry study 1.259
COR758, a negative allosteric modulator of GABAB receptors 1.153
Methamphetamine-induced damages of serotoninergic and dopaminergic terminals are not paralleled by overt mnemonic and pre-attentional alterations 1.147
The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 1.126
Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances 1.056
Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse 1.055
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.040
Predisposition to alcohol drinking and alcohol consumption alter expression of calcitonin gene-related peptide, neuropeptide Y, and microglia in bed nucleus of stria terminalis in a subnucleus-specific manner 1.000
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 949
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists 869
Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911 847
Distribution of GABA B receptor mRNAs in the rat brain and peripheral organs 780
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 764
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists 722
Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid 715
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 702
Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations 660
Thyroid transcription factor 1 activates the promoter of the tyrothropin receptor gene 653
Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic patients 653
Immune and glial cell alterations in the rat brain after repeated exposure to the synthetic cannabinoid JWH-018 638
Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into gamma-hydroxybutyric acid 634
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists 629
Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain 627
CATHEPSIN-G INDUCED RELEASE OF PAI-1 IN THE CULTURE-MEDIUM OF ENDOTHELIAL-CELLS - A NEW THROMBOGENIC ROLE FOR POLYMORPHONUCLEAR LEUKOCYTES 600
Molecular pharmacology of the Beta-adrenergic receptor on THP-1 cells 583
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor 576
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 576
Recombinant cytokines IL-2, IL-1, IFN-G, G-CSF and GM-CSF augment CFU-C activity in normal, cyclophosphamide-treated or irradiated mice as well as reduce the lethality of these myelotoxic agents 571
Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)-thiophene-3-carboxamides and analogues thereof 548
Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors 548
Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients 546
Effects of Antiestrogen and Progestin on Immune Functions in Breast Cancer Patients 511
Regioselective synthesis of new EWG-Bearing 3-benzoyl-2-phenylbenzofurans by one-pot intramolecular acylation/thermal cyclization of phosphoranes and their CB1 antagonist activity 494
null 448
Correlations between Gustatory, Olfactory, Cognitive Function, and Age in Healthy Women 434
Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity 299
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 290
null 281
Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. 223
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 213
Correction to: Adolescent self‑administration of the synthetic cannabinoid receptor agonist JWH‑018 induces neurobiological and behavioral alterations in adult male mice 173
The novel synthesized naltrexone-related MOR antagonist AT-99 counteracts dopamine releasing and behavioral depressant morphine-induced effects 98
Maternal immune activation with high molecular weight poly (I:C) induces selective depressive-like phenotype in adult offspring 34
The PPARα agonist fenofibrate reduces the cytokine imbalance in a maternal immune activation model of schizophrenia 18
Totale 145.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.363 0 634 608 439 637 731 503 406 488 724 1.197 996
2022/202311.794 1.081 1.320 1.207 976 906 1.542 559 834 821 866 1.130 552
2023/202411.633 608 476 452 640 1.130 1.776 1.899 760 667 786 1.221 1.218
2024/202517.382 3.469 4.091 2.513 2.375 1.338 1.280 1.225 146 280 185 239 241
2025/20268.692 488 336 919 459 490 410 1.313 568 2.249 871 370 219
2026/20271.341 533 808 0 0 0 0 0 0 0 0 0 0
Totale 145.507